Clinical Trial: Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title:

Brief Summary: This trial will study the percentage of women with at least one occurrence of intracyclic bleeding (bleeding and/or spotting) during the cycles 2 and 3 of treatment with test or reference drug.

Detailed Summary:
Sponsor: Eurofarma Laboratorios S.A.

Current Primary Outcome: Occurrence of intracyclic bleeding and/or spotting during the cycles 2 and 3 of treatment

Original Primary Outcome: Same as current

Current Secondary Outcome: Percentage of women with intracyclic bleeding during treatment cycles 2 to 7

Original Secondary Outcome: Same as current

Information By: Eurofarma Laboratorios S.A.

Dates:
Date Received: March 8, 2012
Date Started:
Date Completion:
Last Updated: July 24, 2015
Last Verified: March 2012